Models:
Joseph Gordon
joseph-gordon/
ClinicalTrialsElig
0
Downloads: 1
[c09aa8]: / clusters / final9knumclusters / clust_443.txt

Download this file

68 lines (67 with data), 7.0 kB 

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
Activated partial thromboplastin time (aPTT) =< 1.5 x ULN

Activated partial thromboplastin time (aPTT) =< 1.2 x ULN

Activated partial thromboplastin time (aPTT) =< 1.2 X ULN

Activated partial thromboplastin time (APTT) or partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal

Activated partial thromboplastin time (aPTT) =< 1.5 x institutional ULN (for participants on anticoagulation therapy, =< 1.5 x their baseline value)

Activated partial thromboplastin time (aPTT) =< 1.5 x institutional ULN (for participants on anticoagulation therapy, =< 1.5 x their baseline value)

Activated partial thromboplastin time (aPTT) within normal limits

PTT or activated partial thromboplastin time (aPTT) ?5 seconds above institutional ULN

Activated partial thromboplastin time (aPTT) ?1.5 × ULN (Grade ?1).

Activated partial thromboplastin time (APTT) or partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal

Activated partial thromboplastin time/ partial thromboplastin time (aPTT/PTT) ? 1.5 x ULN

Activated partial thromboplastin time (aPTT) > 35.9 seconds

Partial thromboplastin time (PTT)/activated (a)PTT =< 1.5 X institutional ULN normal except if, in the opinion of the investigator, the aPTT is elevated because of a positive lupus anticoagulant (unless dysfunction is secondary to lymphoma involvement)

Activated partial thromboplastin time (aPTT) =< 1.5 X ULN

Partial thromboplastin time (PTT) or activated PTT (aPTT) =< 1.5 x ULN

Activated partial thromboplastin time (aPTT) =< 1.5 x ULN (unless on prophylactic or therapeutic dosing with low molecular weight heparin) (obtained within 28 days prior to first study treatment)

Activated partial thromboplastin time (aPTT) within 1.25 x ULN institutional limits, except where a lupus anti-coagulant has been confirmed

Activated partial thromboplastin time (aPTT) < 1.5 x ULN

Partial thromboplastin time (PTT) (PTT/activated partial thromboplastin time [aPTT]) < 1.5 x ULN)

Within 3 months of registration: Activated partial thromboplastin time (aPTT) =< 1.5 x ULN (unless on prophylactic or therapeutic dosing with low molecular weight heparin)

Activated partial thromboplastin time (aPTT) =< 1.5 x ULN for the laboratory

Activated partial thromboplastin time (aPTT) =< 1.2 x IULN

Activated partial thromboplastin time (aPTT) =< 1.5 x ULN unless the patient is receiving anticoagulant therapy

Activated partial thromboplastin time (aPTT) =< 1.2 x ULN

Activated partial thromboplastin time/ partial thromboplastin time (aPTT/PTT) ?1.5 x ULN

Activated partial thromboplastin time (aPTT) =< 1.5 x ULN or within therapeutic range if receiving anticoagulant therapy OR

Activated partial thromboplastin time (APTT)/PTT =< 1.5 x institutional ULN

Activated partial thromboplastin time (APTT)/partial thromboplastin time (PTT) =< 1.5 x ULN

Activated partial thromboplastin time (aPTT) =< 1.5 x ULN for the laboratory

ARM A: obtained =< 14 days prior to registration: \r\n* Activated partial thromboplastin time (aPTT) =< 1.5 x ULN

Obtained within 30 days prior to registration: Activated partial thromboplastin time (aPTT) =< 2 x ULN (Note: use of vitamin K antagonist is not allowed)

Activated partial thromboplastin time (APTT) or partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal

Activated partial thromboplastin time (aPTT) =< 1.2 x ULN

Activated partial thromboplastin time (APTT) < 1.2 times upper limit of normal (ULN); (Note: use of warfarin is prohibited; low molecular weight heparin is allowed, so long as these criteria are met)

Activated Partial Thromboplastin Time (APTT) patients beeing treated with anticoagulants are excluded if teh coagulation parameters are outside the therapeutic intervals as described in the SmPC/USPI for the administered treatment

Activated Partial Thromboplastin Time (aPTT) ?1.5 X ULN

Activated partial thromboplastin time (aPTT) =< 1.2 x ULN (tested within 14 days prior to registration)

Activated partial thromboplastin time (aPTT) =< 1.2 x ULN

Activated partial thromboplastin time (aPTT) =< 1.2 x IULN

Partial thromboplastin time (PTT) or activated partial thromboplastin time (aPTT) =< upper limit of normal (ULN) per institutional laboratory range

Activated partial thromboplastin time (aPTT) > 1.5 x ULN (patients on heparin treatment must have an aPTT between 1.5 - 2.5 x ULN), or

Activated partial thromboplastin time (aPTT) =< 1.5 x institutional upper limits of normal

Activated partial thromboplastin time (aPTT) =< 1.2 X ULN; subjects receiving anticoagulant therapy are eligible if their aPTT is stable and within the recommended range for the desired level of anticoagulation

Activated partial thromboplastin time (aPTT) =< 1.2 X ULN

Activated partial thromboplastin time (aPTT) =< 1.2 X ULN

Activated partial thromboplastin time (aPTT) =< 1.2 X ULN

Activated partial thromboplastin time (aPTT) =< 1.2 x ULN

Prothrombin time and activated partial thromboplastin time (aPTT) < 1.5 times the upper limit of normal (ULN)

Activated partial thromboplastin time (aPTT) ? 1.5 x the upper limit of the normal range (ULN) per institutional laboratory normal range

Activated partial thromboplastin time (aPTT) ? 1.5 x the upper limit of the normal range (ULN) per institutional laboratory normal range

Activated partial thromboplastin time (APTT) =< 1.5 x upper limit of normal unless patient is receiving anticoagulants; if patient is on anticoagulation therapy, levels should be within therapeutic range

Activated partial thromboplastin time (PTT) < 1.5 x ULN

Activated partial thromboplastin time (APTT)/partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal

aPTT ? 1.5 x ULN

Activated partial thromboplastin time (APTT)/partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal

Activated partial thromboplastin time =< 1.5 times ULN

Activated partial thromboplastin time =< 1.5 times ULN

Activated partial thromboplastin time (aPTT) ? 1.3 × ULN

Abnormal coagulation (partial thromboplastin [PT] or activated partial thromboplastin time [aPTT] > 30% above normal limits)

Within 30 days of surgery: Activated partial thromboplastin time (aPTT) =< 40

Activated partial thromboplastin time (APTT) or partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal

Partial thromboplastin time (PTT) (activated partial thromboplastin time [aPTT]) =< 1.5 times the upper limit of normal

Activated partial thromboplastin time (aPTT) =< 40 (within 30 days of surgery)

Activated partial thromboplastin time (aPTT) within normal institutional limits

Activated partial thromboplastin time (APTT)/partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal

Obtained within 28 days prior to registration: Activated partial thromboplastin time (aPTT) =< 1.5 x ULN (unless on prophylactic or therapeutic dosing with low molecular weight heparin)

Activated partial thromboplastin time (aPTT) or plasma thromboplastin (PT) outside the institution's standard of care.